Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
Mobile healthcare refers to the delivery of medical services and information through the use of mobile communication technologies. Achieve medical services “at your fingertips.” Compared
The newly revised Medical Device Classification Catalog (hereinafter referred to as the “Classification Catalog”) released by China’s State Food and Drug Administration (CFDA) was officially
According to Gartner, 30% of internal medical implants and devices in the medical field will use 3D printing technology by the year 2020. Considering China
On November 23, CFDA issued official Guidelines on Medical Device Registration Unit Classification, which mainly focus on the technical principles, structural components, performance indexes, scope
Ambient Clinical Analytics, a U.S. medical analytics company founded in 2013, just inked a cooperation agreement with Meehealth, a leading Chinese Health IT company that
The new “medical equipment classification directory” In recent years, the rapid development of China’s medical device industry, at present there are about 77,000 valid registration
According to a local news report, an 84-year-old man in China recently became the first patient in the world to receive a 3D-printed tantalum knee
Highlights of CFDA’s Plan To Implement Review and Approval System Reform and Encourage Drug and Medical Device Innovation in China In October 2017, China’s
Ortho Clinical Diagnostics announced that its ORTHO VISION Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories has received approval
China’s Point of Care Testing industry: A billion-dollar market and growing 20-30% annually The rapid growth of the Point of Care Testing Industry and the obvious
China’s In Vitro Diagnosis (IVD) Market is an opportunity for U.S. companies to take their product offering overseas. Here is a current overview of the
EYE TECH CARE, a French medical device company, has received approval from CFDA to begin marketing its EyeOP1® glaucoma treatment product in China. The first